The Indian Pharmacopoeia Commission and Central Drugs Standard Control Organization published the first version of the guidance in 2018. Later, an expert committee worked to revise the text, leading to the publication of a draft copy for consultation. Most of the final text is unchanged from the draft version, but the authorities have made some key revisions. @Read More